DE60200089T2 - Octahydro-2H-pyrido[1,2-a]pyrazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen - Google Patents

Octahydro-2H-pyrido[1,2-a]pyrazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen Download PDF

Info

Publication number
DE60200089T2
DE60200089T2 DE60200089T DE60200089T DE60200089T2 DE 60200089 T2 DE60200089 T2 DE 60200089T2 DE 60200089 T DE60200089 T DE 60200089T DE 60200089 T DE60200089 T DE 60200089T DE 60200089 T2 DE60200089 T2 DE 60200089T2
Authority
DE
Germany
Prior art keywords
formula
compounds
octahydro
pyrido
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60200089T
Other languages
German (de)
English (en)
Other versions
DE60200089D1 (de
Inventor
Solo Goldstein
Guillaume Poissonnet
Jean-Gilles Parmentier
Pierre Lestage
Brian Lockhart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of DE60200089D1 publication Critical patent/DE60200089D1/de
Application granted granted Critical
Publication of DE60200089T2 publication Critical patent/DE60200089T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60200089T 2001-07-12 2002-07-11 Octahydro-2H-pyrido[1,2-a]pyrazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen Expired - Fee Related DE60200089T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109260A FR2827288B1 (fr) 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR0109260 2001-07-12

Publications (2)

Publication Number Publication Date
DE60200089D1 DE60200089D1 (de) 2003-12-18
DE60200089T2 true DE60200089T2 (de) 2004-09-09

Family

ID=8865405

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60200089T Expired - Fee Related DE60200089T2 (de) 2001-07-12 2002-07-11 Octahydro-2H-pyrido[1,2-a]pyrazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Country Status (24)

Country Link
US (1) US6992085B2 (https=)
EP (1) EP1275647B1 (https=)
JP (1) JP3950018B2 (https=)
KR (1) KR100485020B1 (https=)
CN (1) CN1197863C (https=)
AR (1) AR036166A1 (https=)
AT (1) ATE254124T1 (https=)
AU (1) AU2002300094B2 (https=)
BR (1) BR0202681A (https=)
CA (1) CA2394027C (https=)
DE (1) DE60200089T2 (https=)
DK (1) DK1275647T3 (https=)
EA (1) EA005160B1 (https=)
ES (1) ES2210219T3 (https=)
FR (1) FR2827288B1 (https=)
HU (1) HUP0202282A3 (https=)
MX (1) MXPA02006699A (https=)
NO (1) NO322966B1 (https=)
NZ (1) NZ520120A (https=)
PL (1) PL355034A1 (https=)
PT (1) PT1275647E (https=)
SI (1) SI1275647T1 (https=)
TR (1) TR200302001T4 (https=)
ZA (1) ZA200205596B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089410A1 (ja) * 2003-04-03 2004-10-21 Kyowa Hakko Kogyo Co., Ltd. 神経因性疼痛の予防及び／または治療剤
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2008503560A (ja) * 2004-06-22 2008-02-07 ファイザー・プロダクツ・インク ジアザビシクロ系のヒスタミン−３受容体アンタゴニスト
RU2499795C2 (ru) * 2005-07-04 2013-11-27 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
CA2646023A1 (en) * 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
KR100871691B1 (ko) 2006-10-16 2008-12-05 삼성전자주식회사 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치
EP3495363B1 (en) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect
EP3744721B1 (en) 2018-01-26 2025-07-02 Shionogi & Co., Ltd. Condensed ring compounds having dopamine d3 receptor antagonistic effect

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
GB8518236D0 (en) * 1985-07-19 1985-08-29 Beecham Group Plc Compounds
WO1994006794A1 (en) * 1992-09-24 1994-03-31 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
WO1996010570A1 (en) * 1994-09-30 1996-04-11 Pfizer Inc. NEUROLEPTIC 2,7-DISUBSTITUTED PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
ES2274795T3 (es) * 1999-07-19 2007-06-01 Merck Frosst Canada Ltd. Pirazinonas, composiciones que contienen tales compuestos.

Also Published As

Publication number Publication date
ES2210219T3 (es) 2004-07-01
NO20023345D0 (no) 2002-07-11
CN1397557A (zh) 2003-02-19
DK1275647T3 (da) 2004-03-15
HUP0202282A2 (hu) 2003-03-28
ATE254124T1 (de) 2003-11-15
MXPA02006699A (es) 2005-08-16
TR200302001T4 (tr) 2004-01-21
KR20030007159A (ko) 2003-01-23
NO322966B1 (no) 2006-12-18
JP2003064081A (ja) 2003-03-05
NZ520120A (en) 2004-03-26
EA200200663A1 (ru) 2003-02-27
HK1050682A1 (en) 2003-07-04
US6992085B2 (en) 2006-01-31
NO20023345L (no) 2003-01-13
SI1275647T1 (en) 2004-02-29
PL355034A1 (en) 2003-01-13
HU0202282D0 (https=) 2002-09-28
AR036166A1 (es) 2004-08-18
DE60200089D1 (de) 2003-12-18
JP3950018B2 (ja) 2007-07-25
KR100485020B1 (ko) 2005-04-25
AU2002300094B2 (en) 2007-06-14
FR2827288A1 (fr) 2003-01-17
FR2827288B1 (fr) 2003-10-31
CN1197863C (zh) 2005-04-20
ZA200205596B (en) 2003-03-27
CA2394027A1 (fr) 2003-01-12
HUP0202282A3 (en) 2003-11-28
EP1275647A1 (fr) 2003-01-15
EP1275647B1 (fr) 2003-11-12
PT1275647E (pt) 2004-03-31
BR0202681A (pt) 2003-05-06
EA005160B1 (ru) 2004-12-30
US20030195216A1 (en) 2003-10-16
CA2394027C (fr) 2008-01-08

Similar Documents

Publication Publication Date Title
DE69008012T2 (de) 4-Fluorbenzolderivate, Herstellungsverfahren und diese enthaltende pharmazeutische Zusammensetzungen.
DE69111029T2 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Verwendung.
DE69425273T2 (de) N-substituierte azabicycloalkanderivate als neuroleptika usw.
DE69132691T2 (de) Indolderivate als 5-HT1-like Agonisten
DE68910210T2 (de) (1-Hydroxy-2-piperidinylalkyl)-2-indolon, 2-quinolinon, 2-benzo[b]azepinon, 2-benzimidazolon und 2-quinazolinon-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung.
DE60009663T2 (de) Piperidin-, tetrahydropyridin- und piperazin-derivate, ihre herstellung und anwendung
EP1499589B1 (fr) Derives de n-¬phenyl(piperidin-2-yl)methyl|benzamide, leur preparation et leur application en therapeutique
DE60305484T2 (de) Verbindungen und deren verwendung als 5-ht inhibitoren
DE60309057T2 (de) Azabicycloderivate als antagonisten des muscarinischen rezeptors
DE69128231T2 (de) Heterozyklische Alkylamine, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
DE69433148T2 (de) Tricyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
DE69105659T2 (de) 3-Arylindol- und 3-Arylindazolderivate.
DE60200089T2 (de) Octahydro-2H-pyrido[1,2-a]pyrazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE60213851T2 (de) Ringannelierte pyrazolderivate
DE69722281T2 (de) 3-Aza-piperidon- (Tetrahydropyrimidin-2-on) und 3-Oxa-piperidon (1,3-Oxazin-2-on) Derivate, deren Herstellung und deren Verwendung als Tachykinin/Neurokinin Antagonisten
DE69922594T2 (de) Indazol-Derivate als 5-HT1F agonists
DD149071A5 (de) Herstellung 2-substituierter trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole
DE69109132T2 (de) Indanderivate.
DE69519047T2 (de) Benzodioxan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DE69329084T2 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
EP0740658B1 (de) N-substituierte azabicycloheptan-derivate und ihre verwendung, z.b., als neuroleptika
DE69110135T2 (de) Neuroleptische perhydro-1h-pyrido(1,2-alpha)pyrazine.
EP0646110B1 (de) N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika
DE60200041T2 (de) Indenoindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltenden pharmazeutischen Zusammensetzungen
DE19746612A1 (de) 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee